Giné Florencia, Donat Marta, Guerras Juan Miguel, Barrio Gregorio, Belza María José, Politi Julieta, Regidor Enrique
Complejo Hospitalario Universitario Insular Materno Infantil, Gran Canaria, Canary Islands, Spain.
National School of Public Health, Carlos III Health Institute, Madrid, Spain.
Addiction. 2025 Jul 10. doi: 10.1111/add.70121.
To measure the evolution of drug overdose mortality in Spain between 2001 and 2022.
DESIGN, SETTING, PARTICIPANTS: A repeated cross-sectional observational study using nationwide mortality data from Spain, 2001-2022, among individuals aged 15-64 years.
The outcome was overdose deaths [International Classification of Diseases, 10th revision (ICD-10) codes: X40-X44, X60-X64, X85, Y10-Y14]. Annual age-standardized mortality rates (ASMRs) per million person-years were estimated. Joinpoint regression assessed changes in trends using annual percentage change (APC) and average APC (AAPC). Overdose deaths were grouped by the underlying drug categories involved: nonopioid analgesics, antipyretics and antirheumatics (X40/X60/Y10); antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs (X41/X61/Y11); narcotics and psychodysleptics (X42/X62/Y12); other drugs acting on the autonomic nervous system (X43/X63/Y13); other and unspecified drugs, medicaments and biological substances (X44/X64/Y14); and drugs, medicaments and biological substances in the context of assault (X85). Intentionality (based on ICD-10 code characters) within the underlying drug categories was assessed. All analyses were stratified by sex.
In Spain, 15 862 overdose deaths occurred during 2001-2022. ASMR increased by 49.0% over the period, from 24.7 [95% confidence interval (95% CI) = 23.0, 26.5] to 36.8 (95% CI = 34.7, 39.0) deaths per million person-years. APC showed a statistically significant change in trends in 2010, shifting from a -3.3% (95% CI = -7.3 to -1.7) decline to an increase of 3.4% (95% CI = -0.3 to 6.5). In 2018, a more abrupt change was observed, with the APC further increasing to 13.8% (95% CI = 9.3, 22.5). Females showed an earlier trend change (2006) with an AAPC 1.7 times higher (3.4%; 95% CI = 2.4, 4.7) than males (2.0%; 95% CI = 1.2, 2.7). Leading drug categories were other and unspecified drugs, medicaments and biological substances, followed by narcotics and psychodysleptics. In males, trends followed the overall pattern; in females, the antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs category predominated, mostly due to intentional overdoses.
Between 2001 and 2022, drug overdose deaths in Spain increased substantially, beginning in 2010 and further accelerated in 2018, though population rates remain low. The most prevalent underlying ICD-10 drug categories were other and unspecified drugs, medicaments and biological substances-likely reflecting polydrug use-and narcotics and psychodysleptics. The observed rise in deaths involving antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, particularly intentional overdoses among females, highlights the need for sex-based interventions.
衡量2001年至2022年西班牙药物过量死亡率的变化情况。
设计、背景、参与者:一项重复横断面观察性研究,使用2001 - 2022年西班牙全国范围内15至64岁个体的死亡率数据。
结局为药物过量死亡[国际疾病分类第10版(ICD - 10)编码:X40 - X44、X60 - X64、X85、Y10 - Y14]。估计了每百万人口年的年龄标准化死亡率(ASMR)。Joinpoint回归使用年度百分比变化(APC)和平均APC(AAPC)评估趋势变化。药物过量死亡按所涉及的潜在药物类别分组:非阿片类镇痛药、解热药和抗风湿药(X40/X60/Y10);抗癫痫药、镇静催眠药、抗帕金森病药和精神药物(X41/X61/Y11);麻醉药和致幻剂(X42/X62/Y12);作用于自主神经系统的其他药物(X43/X63/Y13);其他及未特定的药物、药剂和生物物质(X44/X64/Y14);以及在攻击情况下使用的药物、药剂和生物物质(X85)。评估了潜在药物类别中的故意性(基于ICD - 10编码特征)。所有分析均按性别分层。
在西班牙,2001年至2022年期间发生了15862例药物过量死亡。在此期间,ASMR增加了49.0%,从每百万人口年24.7例[95%置信区间(95%CI)= 23.0,26.5]增至36.8例(95%CI = 34.7,39.0)。APC显示2010年趋势有统计学显著变化,从-3.3%(95%CI = -7.3至-1.7)的下降转变为3.4%(95%CI = -0.3至6.5)的上升。2018年观察到更急剧的变化,APC进一步增至13.8%(95%CI = 9.3,22.5)。女性的趋势变化更早(2006年),其AAPC比男性高1.7倍(3.4%;95%CI = 2.4,4.7)(男性为2.0%;95%CI = 1.2,2.7)。主要药物类别是其他及未特定的药物、药剂和生物物质,其次是麻醉药和致幻剂。在男性中,趋势遵循总体模式;在女性中,抗癫痫药、镇静催眠药、抗帕金森病药和精神药物类别占主导,主要是由于故意过量用药。
2001年至2022年期间,西班牙的药物过量死亡大幅增加,始于2010年并在2叭8年进一步加速,尽管总体发生率仍然较低。最常见的潜在ICD - 10药物类别是其他及未特定的药物、药剂和生物物质(可能反映多药使用情况)以及麻醉药和致幻剂。观察到涉及抗癫痫药、镇静催眠药、抗帕金森病药和精神药物的死亡人数上升,特别是女性中的故意过量用药,凸显了基于性别的干预措施的必要性。